Capillary Film Technology Receives £98K Funding
News Apr 08, 2014

Capillary Film Technology Limited (CFT) announced it has received £98K in funding as part of a Small Business Research Initiative for Healthcare (SBRI Healthcare) development contract. The funding will be used to develop a cost-effective and fully quantitative multiplexed point-of-care (POC) testing technology to aid in the assessment of acute coronary syndrome.
The POC diagnostic is based on CFT’s FluorEx™ technology, a low-cost microfluidic fluoropolymer film that possesses unique optical transparency. FluorEx uses a parallel array of 10 x 200 micron capillaries to enable rapid fully quantitative immunoassays to be incorporated in existing or emergent diagnostic technologies. The technology has the potential to provide a cost effective quantitative option for diagnosing acute coronary syndrome, resulting in reduced waiting times and improved treatment for patients. CFT’s FluorEx technology is available for licensing.
Commenting on the funding, Dr Lee Smith, CEO at CFT, said: “Our vision is to develop a next-generation lateral flow diagnostic testing technology that can measure multiple clinically relevant biomarkers, such as those used to select treatments for patients presenting with symptoms of acute cardiac syndrome, but with the low cost and simplicity required by emergency medics, paramedics, and GPs. This funding will enable us to focus on developing a diagnostic technology that meets the specific needs of NHS patients, and ultimately improve the health of patients suffering from heart attacks.”
RELATED ARTICLES
Identifying Vampire Victims
NewsVampire bats feast on blood from domestic animals and can pass on blood-borne diseases such as rabies in the process. A new DNA analysis technique will make identifying the bat's victims far easier, hopefully simplifying disease control.
READ MOREAn Artificial Mole As An Early Warning Sign
NewsETH researchers have developed an early warning system for the four most common types of cancer. Should a tumour develop, a visible mole will appear on the skin.
READ MORELiquid Biopsy Developed for Multiple Myeloma
NewsChip-based blood test for multiple myeloma could make bone biopsies a relic of the past.
READ MOREComments | 0 ADD COMMENT
Like what you just read? You can find similar content on the communities below.
DiagnosticsTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREEInternational Conference on Analytical and Bio Analytical Techniques
Oct 31 - Nov 01, 2018
6th International Conference on Neurodegenerative Disorders and Stroke
Oct 22 - Oct 23, 2018
16th Annual Conference on Laboratory Medicine and Pathology
Sep 17 - Sep 18, 2018
Login
You must be logged in to post a comment.